Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Arnold Bolomsky,
Meike Vogler,
Murat Cem Köse,
Caroline A. Heckman,
Grégory Ehx,
Heinz Ludwig,
Jo Caers
Affiliations
Arnold Bolomsky
Wilhelminen Cancer Research Institute, Wilhelminenspital
Meike Vogler
Institute for Experimental Cancer Research in Pediatrics, Goethe-University
Murat Cem Köse
Department of Clinical Hematology, GIGA-I3, University of Liège, CHU De Liège
Caroline A. Heckman
Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki
Grégory Ehx
Department of Clinical Hematology, GIGA-I3, University of Liège, CHU De Liège
Heinz Ludwig
Wilhelminen Cancer Research Institute, Wilhelminenspital
Jo Caers
Department of Clinical Hematology, GIGA-I3, University of Liège, CHU De Liège
